Logo (Actavis) 455 Pill - white round, 15mm
Pill with imprint Logo (Actavis) 455 is White, Round and has been identified as Deferasirox (for Oral Suspension) 250 mg. It is supplied by Actavis Pharma, Inc.
Deferasirox is used in the treatment of Iron Overload; Thalassemia; Hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 455
Deferasirox (for Oral Suspension)
- Imprint
- Logo (Actavis) 455
- Strength
- 250 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Chelating agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 45963-0455
See also:
Jadenu
Jadenu (deferasirox) treats iron overload by binding to iron and removing it from the bloodstream ...
Exjade
Exjade is used to treat iron overload caused by blood transfusions. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ferriprox
Ferriprox (deferiprone) is used to treat patients with iron overload caused by blood transfusions ...
Deferiprone
Deferiprone is used for hemosiderosis, iron overload, superficial siderosis, thalassemia
More about deferasirox
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: chelating agents
- Breastfeeding
- En español
Patient resources
- Deferasirox drug information
- Deferasirox (Advanced Reading)
- Deferasirox Tablets
- Deferasirox Tablets For Oral Suspension
Other brands
Jadenu, Exjade, Jadenu Sprinkle
Professional resources
- Deferasirox monograph
- Deferasirox (FDA)
- Deferasirox Tablets (FDA)
- Deferasirox Tablets for Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.